YOLFTbeta
Impedimed Ltd

Impedimed Ltd

IPD · AU · Healthcare / Medical Devices

0.004AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.004
Open0.004
Day Range0.004 – 0.004
52-Week Range0.003 – 0.052
Volume510
Market Cap21.97M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta1.07
50-Day Avg0.005
200-Day Avg0.0129

About

ImpediMed Limited, a medical technology company, engages in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services in Australia, Europe, North America, and internationally. The company offers SOZO Digital Health Platform which transforms fluid status and tissue composition into insights with a single scan; L-Dex Analysis for Lymphedema, designed for early lymphedema detection; BodyComp Analysis; Segmental BodyComp Analysis; and HF-Dex Analysis for Heart Failure. It also provides Lymphedema Prevention Program; and BodyComp Analysis for survivorship health. The company specializes in cancer survivorship, heart health management, medical weight management, wellness, and research. ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Erik Anderson
  • Employees66
  • Headquarters5900 Pasteur Court, Carlsbad, CA, United States, 92008, Australia
  • Websitehttps://www.impedimed.com

Leadership

  • Mr. Erik AndersonCEO, MD & Director
  • Mr. McGregor Grant BEc, C.A., FCIS, GAICDCFO & Executive Director
  • Ms. Julie KuhlkenSenior Director of Marketing
  • Erik JohnsonHead of Sales
  • Ms. Ashley MunozDirector of Human Resources
  • Ms. Gina KimballHead of Commercial Operations
  • Ms. Leanne Ralph AAICD, ACIS, BBusCompany Secretary

Financials

Income Statement

Currency: AUD2005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue281.00K1.07M1.21M2.31M2.99M3.64M3.89M2.94M2.73M3.52M4.84M5.79M5.77M3.32M4.16M5.74M8.41M10.57M11.34M10.32M12.72M14.61M
Growth (%)-+281.14%+13.35%+90.40%+29.44%+21.63%+6.82%-24.23%-7.20%+28.83%+37.57%+19.55%-0.43%-42.46%+25.26%+38.14%+46.47%+25.65%+7.36%-9.04%+23.31%+14.85%
Cost of Revenue155.00K2.07M629.00K693.60K1.43M1.61M1.66M1.26M1.17M968.00K1.32M1.58M1.49M976.00K1.25M18.63M20.61M23.92M25.00M1.31M1.75M26.50M
Gross Profit---1.62M1.56M2.03M2.23M1.68M1.56M2.55M3.52M4.21M4.28M2.34M2.90M-12.89M-12.20M-13.35M-13.65M9.01M10.97M-11.89M
Gross Margin---69.99%52.30%55.78%57.40%57.05%57.04%72.51%72.67%72.66%74.18%70.58%69.87%-224.49%-145.11%-126.35%-120.36%87.27%86.25%-81.36%
Operating Expense---11.43M15.73M13.72M17.48M15.14M11.01M10.56M18.66M32.71M35.06M33.05M29.86M12.62M10.81M7.88M9.19M28.04M35.21M10.22M
Operating Income----9.81M-14.17M-11.69M-15.25M-13.46M-9.45M-8.01M-15.14M-28.50M-30.78M-30.71M-26.96M-25.51M-23.02M-21.23M-22.85M-19.04M-24.23M-22.11M
Operating Margin----424.37%-473.45%-321.30%-392.44%-457.22%-345.66%-227.52%-312.65%-492.13%-533.82%-925.62%-648.70%-444.35%-273.72%-200.90%-201.39%-184.48%-190.44%-151.27%
EBITDA----7.71M-13.25M-10.66M-14.14M-12.89M-9.24M-7.83M-14.97M-26.00M-30.52M-30.35M-26.33M-24.07M-20.70M-18.65M-20.49M-22.05M-17.55M-22.11M
EBITDA Margin----333.58%-442.85%-293.05%-363.88%-437.72%-338.05%-222.52%-309.04%-448.89%-529.29%-914.65%-633.54%-419.33%-246.20%-176.51%-180.65%-213.69%-137.95%-151.27%
Net Income----9.75M-14.03M-11.40M-14.82M-12.34M-8.46M-7.93M-14.80M-25.98M-27.57M-27.25M-24.00M-21.38M-20.71M-19.87M-20.52M-19.79M-23.24M-24.91M
Net Income Margin----422.00%-468.85%-313.33%-381.32%-419.08%-309.70%-225.36%-305.47%-448.63%-478.17%-821.22%-577.38%-372.36%-246.24%-188.09%-180.90%-191.78%-182.62%-170.44%
R&D-46.00K-1.83M2.93M1.26M1.38M2.78M554.00K401.00K1.03M4.04M5.34M2.96M3.37M3.31M1.46M683.00K598.00K221.00K150.00K-
R&D as % of Total Revenue-4.30%-79.08%97.85%34.76%35.48%94.50%20.27%11.39%21.37%69.78%92.54%89.33%80.97%57.62%17.31%6.46%5.27%2.14%1.18%-
Interest Expense0001.69M5.94K1.00K13.00K0000028.00K445.00K2.94M73.00K52.00K28.00K34.00K93.00K1.09M3.73M
Interest Expense % of Total Revenue0.00%0.00%0.00%73.06%0.20%0.03%0.33%0.00%0.00%0.00%0.00%0.00%0.49%13.41%70.74%1.27%0.62%0.27%0.30%0.90%8.60%25.50%

Balance Sheet

Currency: AUD2006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets4.63M21.79M14.52M13.10M24.91M22.80M19.61M11.86M14.96M37.92M90.57M64.34M41.57M22.58M33.06M34.20M58.70M68.74M46.99M41.66M34.66M
Total Liabilities9.31M2.39M2.21M3.03M2.68M2.12M2.30M1.27M1.43M3.08M5.32M5.55M5.76M6.80M5.70M8.69M7.66M7.86M6.24M21.16M24.47M
Total Equity-19.40M12.30M10.07M22.23M20.68M17.31M10.59M13.53M34.84M85.25M58.80M35.80M15.79M27.36M25.51M51.04M60.88M40.74M20.50M10.19M
Cash-16.27M8.49M6.63M18.79M17.93M14.54M7.32M10.81M32.58M82.25M54.88M31.34M11.33M19.66M19.68M40.73M45.71M24.63M22.18M15.29M
Total Debt-775.45K64.02K----------871.00K871.00K474.00K170.00K1.45M1.14M14.49M16.60M
Net Debt--15.49M-8.42M-6.63M-18.79M-17.93M-14.54M-7.32M-10.81M-32.58M-82.25M-54.88M-31.34M-11.33M-18.79M-19.21M-40.56M-44.26M-23.49M-7.69M1.31M

Cash Flow

Currency: AUD2006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow---7.42M-11.79M-10.39M-11.30M-11.80M-7.67M-6.80M-10.76M-22.42M-25.57M-23.46M-19.59M-19.22M-13.26M-15.66M-18.05M-17.79M-14.64M-20.03M
Investing Cash Flow---1.65M-755.41K-76.00K--93.00K-37.00K-32.00K-132.00K-109.00K-362.00K-1.22M-1.76M-2.16M-2.46M-5.22M-6.04M-3.10M-989.00K-1.27M
Financing Cash Flow2.13M10.22M15.90M10.63M23.07M13.45M8.14M34.00K10.59M30.66M71.46M720.00K256.00K145.00K30.16M16.47M39.92M27.93M-481.00K13.64M15.90M
Capital Expenditure81.00K103.00K1.73M765.41K76.00K093.00K16.00K32.00K132.00K109.00K335.00K155.00K34.00K2.16M2.46M5.22M6.04M3.10M989.00K67.00K
Free Cash Flow---9.15M-12.55M-10.46M-11.30M-11.89M-7.69M-6.83M-10.89M-22.53M-25.90M-23.61M-19.62M-21.38M-15.71M-20.89M-24.09M-20.89M-15.63M-20.10M
Dividends Paid--46.13K513.20K------00--413.00K580.00K373.00K425.00K---
FCF to OCF--123.38%106.49%100.73%100.00%100.79%100.21%100.47%101.23%100.49%101.31%100.66%100.17%111.24%118.53%133.33%133.48%117.45%106.75%100.33%
Dividend Paid to FCF---0.50%-4.09%------0.00%0.00%---1.93%-3.69%-1.79%-1.76%---

Earnings

Report DateFeb 24, 2014Feb 24, 2016Aug 24, 2016Feb 23, 2017Apr 19, 2017Aug 22, 2017Feb 22, 2018Apr 25, 2018Aug 29, 2018Nov 28, 2018Feb 20, 2019Apr 25, 2019Aug 20, 2019Nov 27, 2019Feb 19, 2020Apr 23, 2020Aug 25, 2020Dec 2, 2020Jan 28, 2021Apr 6, 2021Aug 24, 2021Oct 26, 2021Feb 24, 2022Apr 27, 2022Aug 8, 2022Oct 19, 2022Feb 24, 2023Apr 17, 2023Aug 31, 2023Oct 31, 2023Feb 26, 2024Apr 30, 2024Aug 28, 2024Nov 29, 2024Feb 25, 2025May 30, 2025Aug 27, 2025Oct 30, 2025Apr 30, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.00-0.030.000.000.000.000.000.000.00-0.00-0.00-0.010.00-0.010.00-0.010.00-0.010.00-0.000.00-0.010.000.000.000.00
EPS Actual0.00-0.04-0.04-0.040.00-0.04-0.040.00-0.030.00-0.030.00-0.030.00-0.030.00-0.010.00-0.010.00-0.010.00-0.010.00-0.010.00-0.010.000.000.000.000.000.000.000.000.00-0.010.000.00
Surprise------------0.00%------------66.67%-0.00%-100.00%-100.00%-100.00%-100.00%----
Timing------------------Pre-market---After-hours-After-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-market-------

Key Statistics & Ratios

Market Cap21.97M
Enterprise Value19.62M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.73
Price / Book1.80
EPS-0.01
Book Value0.003
Revenue (TTM)14.61M
Gross Profit (TTM)12.77M
EBITDA-21.14M
Profit Margin-170.44%
Operating Margin-146.22%
Return on Equity-162.35%
Return on Assets-34.79%
Shares Outstanding3.66B
Shares Float3.33B
Beta1.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
21.05%
Insiders
9.20%
Retail / Other
69.75%

Top Fund Holders

  • DFA Asia Pacific Small Company Series
    417.44K0.03%

Stock Splits

  • Apr 3, 2020368:355
  • Jul 1, 201992:91
  • Nov 17, 2014112:109
  • May 3, 2012215:207
  • Apr 9, 2010213:211
  • Jun 1, 200950:49